ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/08/09 | 1,366 | 1,385 | 1,358 | 1,369 | -2 | -0.1% | 401,000 |
2018/08/08 | 1,401 | 1,401 | 1,366 | 1,371 | -35 | -2.5% | 622,500 |
2018/08/07 | 1,380 | 1,421 | 1,371 | 1,406 | +25 | +1.8% | 923,100 |
2018/08/06 | 1,374 | 1,397 | 1,368 | 1,381 | +12 | +0.9% | 607,800 |
2018/08/03 | 1,374 | 1,406 | 1,367 | 1,369 | -5 | -0.4% | 764,800 |
2018/08/02 | 1,378 | 1,404 | 1,366 | 1,374 | -2 | -0.1% | 533,800 |
2018/08/01 | 1,396 | 1,411 | 1,376 | 1,376 | -20 | -1.4% | 563,300 |
2018/07/31 | 1,371 | 1,399 | 1,367 | 1,396 | +15 | +1.1% | 504,300 |
2018/07/30 | 1,422 | 1,437 | 1,377 | 1,381 | -41 | -2.9% | 799,500 |
2018/07/27 | 1,393 | 1,429 | 1,375 | 1,422 | +32 | +2.3% | 612,100 |
2018/07/26 | 1,408 | 1,432 | 1,371 | 1,390 | -26 | -1.8% | 1,067,700 |
2018/07/25 | 1,429 | 1,475 | 1,406 | 1,416 | -19 | -1.3% | 1,116,300 |
2018/07/24 | 1,355 | 1,475 | 1,355 | 1,435 | +104 | +7.8% | 3,203,400 |
2018/07/23 | 1,336 | 1,352 | 1,325 | 1,331 | +2 | +0.2% | 602,100 |
2018/07/20 | 1,336 | 1,369 | 1,308 | 1,329 | -20 | -1.5% | 1,310,200 |
2018/07/19 | 1,403 | 1,405 | 1,338 | 1,349 | -35 | -2.5% | 728,300 |
2018/07/18 | 1,376 | 1,397 | 1,365 | 1,384 | +8 | +0.6% | 812,300 |
2018/07/17 | 1,392 | 1,398 | 1,366 | 1,376 | -36 | -2.5% | 540,800 |
2018/07/13 | 1,420 | 1,423 | 1,395 | 1,412 | -2 | -0.1% | 703,700 |
2018/07/12 | 1,395 | 1,456 | 1,388 | 1,414 | +32 | +2.3% | 750,500 |
2018/07/11 | 1,414 | 1,424 | 1,342 | 1,382 | -32 | -2.3% | 886,400 |
2018/07/10 | 1,409 | 1,455 | 1,409 | 1,414 | +2 | +0.1% | 903,500 |
2018/07/09 | 1,425 | 1,442 | 1,403 | 1,412 | +25 | +1.8% | 841,100 |
2018/07/06 | 1,363 | 1,413 | 1,340 | 1,387 | +54 | +4.1% | 2,133,600 |
2018/07/05 | 1,427 | 1,479 | 1,304 | 1,333 | -115 | -7.9% | 3,230,000 |
2018/07/04 | 1,466 | 1,504 | 1,433 | 1,448 | -26 | -1.8% | 1,180,500 |
2018/07/03 | 1,581 | 1,596 | 1,414 | 1,474 | -110 | -6.9% | 2,973,700 |
2018/07/02 | 1,771 | 1,774 | 1,584 | 1,584 | -200 | -11.2% | 1,872,700 |
2018/06/29 | 1,745 | 1,784 | 1,734 | 1,784 | +51 | +2.9% | 488,100 |
2018/06/28 | 1,775 | 1,779 | 1,729 | 1,733 | -59 | -3.3% | 435,600 |
2018/06/27 | 1,763 | 1,820 | 1,754 | 1,792 | +57 | +3.3% | 922,900 |
2018/06/26 | 1,672.5 | 1,745 | 1,662.5 | 1,735 | +37.5 | +2.2% | 559,600 |
2018/06/25 | 1,710 | 1,752.5 | 1,692.5 | 1,697.5 | +5 | +0.3% | 656,800 |
2018/06/22 | 1,690 | 1,722.5 | 1,682.5 | 1,692.5 | -17.5 | -1% | 727,600 |
2018/06/21 | 1,657.5 | 1,727.5 | 1,657.5 | 1,710 | +32.5 | +1.9% | 716,000 |
2018/06/20 | 1,645 | 1,682.5 | 1,595 | 1,677.5 | +40 | +2.4% | 972,800 |
2018/06/19 | 1,682.5 | 1,690 | 1,610 | 1,637.5 | -60 | -3.5% | 1,394,000 |
2018/06/18 | 1,715 | 1,725 | 1,685 | 1,697.5 | -15 | -0.9% | 530,000 |
2018/06/15 | 1,730 | 1,737.5 | 1,712.5 | 1,712.5 | -7.5 | -0.4% | 369,600 |
2018/06/14 | 1,710 | 1,740 | 1,710 | 1,720 | ±0 | ±0% | 447,200 |
2018/06/13 | 1,747.5 | 1,770 | 1,710 | 1,720 | -17.5 | -1% | 905,600 |
2018/06/12 | 1,752.5 | 1,775 | 1,735 | 1,737.5 | +15 | +0.9% | 967,600 |
2018/06/11 | 1,712.5 | 1,735 | 1,702.5 | 1,722.5 | +22.5 | +1.3% | 613,600 |
2018/06/08 | 1,660 | 1,705 | 1,657.5 | 1,700 | +35 | +2.1% | 786,800 |
2018/06/07 | 1,627.5 | 1,685 | 1,617.5 | 1,665 | +37.5 | +2.3% | 1,528,800 |
2018/06/06 | 1,702.5 | 1,705 | 1,625 | 1,627.5 | -100 | -5.8% | 2,656,800 |
2018/06/05 | 1,875 | 1,875 | 1,695 | 1,727.5 | -160 | -8.5% | 3,978,000 |
2018/06/04 | 1,875 | 1,895 | 1,847.5 | 1,887.5 | +50 | +2.7% | 839,600 |
2018/06/01 | 1,807.5 | 1,862.5 | 1,807.5 | 1,837.5 | +15 | +0.8% | 881,200 |
2018/05/31 | 1,755 | 1,827.5 | 1,740 | 1,822.5 | +72.5 | +4.1% | 1,336,800 |
1501~
1550
件表示中 / 4943件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 126,400円 | +197.7% | - | 0.00% | 51.65倍 | 1.65倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
持田薬 | 345,500円 | +3.0% | +27.5% | 2.32% | 21.87倍 | 0.95倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 234,200円 | +9.6% | +17.5% | 1.96% | 13.23倍 | 1.30倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 392,000円 | +11.1% | +20.6% | 3.06% | 22.96倍 | 0.92倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
杏林製薬 | 153,700円 | +3.2% | +4.5% | 3.38% | 17.66倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム